From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ESMO 2025 signal a shift toward precision-guided adjuvant care.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ctdna-guided-care-where-are-we-bladder-and-colon-cancer-2025a1000ssm?src=rss
Author :
Publish date : 2025-10-23 04:54:00
Copyright for syndicated content belongs to the linked Source.
